All In MedTech

FDA Clearance Tracker · P090022-S010

SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 11, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 11, 2012

Approved

Time to decision

191 days

Received Nov 2, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P090022-S010
Device name
SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS
Applicant
Lenstec, Inc.
Applicant location
St. Petersburg, FL
Received
Nov 2, 2011
Decided
May 11, 2012
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P090022

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED IN PETERSBURG, FLORIDA.

Source documents

Other decisions for Lenstec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.